Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial

BMJ (Clinical research ed.)

Volumn 350, Issue , 2015, Pages h2219-

  Paul, Mical ^a   Bishara, Jihad ^a   Yahav, Dafna ^a   Goldberg, Elad ^a   Neuberger, Ami ^a   Ghanem Zoubi, Nesrin ^a   Dickstein, Yaakov ^a   Nseir, William ^a   Dan, Michael ^a   Leibovici, Leonard ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE; VANCOMYCIN;

ADULT; BACTEREMIA; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; ISRAEL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MULTICENTER STUDY; ODDS RATIO; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCAL INFECTIONS;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; ISRAEL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; ODDS RATIO; STAPHYLOCOCCAL INFECTIONS; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION; VANCOMYCIN;

EID: 84964694803     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h2219     Document Type: Article

References (0)